The research focus of Boris Prilutsky's laboratory is Neural Control and Biomechanics of Movement. They study how the nervous system controls hundreds of muscles and kinematic degrees of freedom of the body to produce purposeful motor behaviors and how the neural control of motor behaviors is affected by neural and musculoskeletal injuries.

Research in the Peroni laboratory focuses on the use of regenerative therapies ranging from cellular to blood derived products to treat musculoskeletal injuries, with a concentration on minimally invasive surgery such as laparoscopy, thoracoscopy and arthroscopy.

Current research project: The surgery, performed in May, is the second successful feline kidney transplant using feline adult stem cells performed at the hospital. “To the best of our knowledge, UGA is the only veterinary facility in the world to use adult stem cells in feline kidney transplantation,” said Dr. Chad Schmiedt, a board-certified small animal surgeon who heads UGA’s feline kidney transplant program.

The service laboratory is managed by research professionals Merrilee Thoresen and Jenny Mumaw, who is enrolled in the college’s doctor of veterinary medicine program and will graduate in 2016. The service is headed by Dr. John Peroni, a board-certified large animal surgeon and associate professor whose research focus includes stem cell therapeutics. Read More

Dr. Alexandra Peister is an associate professor in the Biology Department at Morehouse College.

Jay Patel, Ph.D., is an Assistant Professor in the Department of Orthopaedics at Emory and a Health Science Specialist at the Atlanta VA. Patel joined the faculty at Emory in September 2020, and his program focuses on the repair and regeneration of musculoskeletal tissues (e.g., cartilage, meniscus), with an emphasis on using micro-scale findings to drive macro-scale therapies. His lab uses a combination of biomechanics, biomaterials, mechano-biology, in vitro systems, and functional in vivo models to motivate, design, develop, and evaluate novel treatments and therapeutics for orthopaedic injuries. He received his Bachelor’s in Bioengineering from Rice University and his Ph.D. in Biomedical Engineering from Rutgers University. He then pursued his postdoctoral training at the University of Pennsylvania in the Department of Orthopaedic Surgery, working on a variety of cartilage tissue engineering and mechano-biology projects. Patel has published over 20 manuscripts, has presented at numerous international conference meetings, and won several prestigious awards, including the Excellence in Research Award (2018) from the American Orthopaedic Society for Sports Medicine. Moreover, both his graduate and postdoctoral work resulted in pending patent applications, and the formation of startup companies with active small-business funding, demonstrating his ultimate goal of translating these approaches to the clinic.
 

Dr. Pardue is a Research Career Scientist at the Atlanta VA Medical Center, and a Professor in Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University School of Medicine. Dr. Pardue received her B.S. in zoology from the University of Wyoming and her doctorate in vision science and biology at the University of Waterloo. Her post-doctorate training in visual electrophysiology was completed with Dr. Neal Peachey at Loyola School of Medicine and Hines VA Hospital in Chicago and focused on biocompatibility of retinal prosthetics. Dr. Pardue moved to Atlanta in 2000 to join the Atlanta VA Medical Center and Emory University Department of Ophthalmology. She moved her academic appointment to Biomedical Engineering in 2015. Her research interests are focused on developing treatments for people with vision loss. To this end, she has developed three research themes within her lab: 1) neuroprotective and restorative treatments for retinal degeneration, 2) early detection and treatment of diabetic retinopathy, and 3) retinal mechanisms of refractive development and myopia. Her research has been continuously supported by the Department of Veterans Affairs, NIH, and private companies (1999-present). She has served on several VA and NIH grant review panels and frequently reviews manuscripts for several journals including Journal of Neuroscience, Investigative Ophthalmology and Visual Sciences, Molecular Vision, Vision Research, Journal of Neuroscience Methods, Journal of Neurochemistry and PlosOne.

Anant Paravastu holds bachelors (MIT, 1998) and Ph.D. degrees (UC Berkeley, 2004) in chemical engineering. His Ph.D. research with Jeffrey Reimer focused on the use of lasers to control nuclear spin polarizations in the semiconductor GaAs. From 2004 to 2007, he worked as a postdoc at the Laboratory of Chemical Physics at NIH with Robert Tycko, where he learned to apply nuclear magnetic resonance to structural biology. Paravastu’s early structural biology work focused amyloid fibrils of the Alzheimer’s β-amyloid peptide. He was part of the team and community that showed that amyloid fibril formation is a complex phenomenon, with individual peptides exhibiting multiple aggregation pathways capable of producing multiple distinct aggregated structures. Between 2008 and 2015, Paravastu worked as an assistant professor at Florida State University and the National High Magnetic Field Laboratory. Paravastu started his present position at Georgia Tech in 2015. Paravastu’s laboratory presently focuses on 3 general lines of inquiry: 1) structural analysis of peptides that were rationally designed to assemble into nanostructured materials, 2) nonfibrillar aggregates of the Alzheimer’s β-amyloid peptide, and 3) aggregation due to misfolding of proteins driven away from their natural folds.

Dr. Oshinski is known for his efforts at advancing the collaboration between Emory University and the Georgia Institute of Technology, as well as his dedication to advancing the technologies of MR imaging. He received his undergraduate degree from Kalamazoo College and BS, MS, and PhD from Georgia Institute of Technology. The underlying mission of his research is the application of engineering principles and technical problem-solving techniques to current clinical problems in the imaging, diagnosis, and treatment of cardiovascular disease. His research has concentrated on developing imaging applications that directly impact disease diagnosis and patient care.

Hang Lu received her B.S. from the University of Illinois, Urbana-Champaign and her M.S.C.E.P and Ph.D. from the Massachusetts Institute of Technology. She is currently the Associate Dean for Research and Innovation in the College of Engineering and C. J. "Pete" Silas Chair, School of Chemical & Biomolecular Engineering at the Georgia Institute of Technology. Lu's research interests involve the interface of engineering and biology and her lab, the Lu Fluidics Group, is conducting research at these interface levels. The Lu Fluidics Group engineers BioMEMS (Bio Micro-Electro-Mechanical System) and microfluidic devices to address questions in neuroscience, cell biology, and biotechnology that are difficult to answer using conventional techniques.

Faces of Research - Profile Article

Dr. Levit came to Emory in 2007 after graduating from the University Of Pennsylvania School Of Medicine. She spent 7 years doing research and clinical training in cardiovascular disease. In 2014 she joined the faculty in the Division of Cardiology and is continuing her work on clinically translatable stem cell therapies for cardiovascular disease.

Aaron D. Levine is Associate Dean for Research and Outreach in the Ivan Allen College of Liberal Arts and Professor in the School of Public Policy at Georgia Tech. He also holds an appointment as a Guest Researcher in the Division of Reproductive Health at the Centers for Disease Control and Prevention. He is a member of the leadership team for the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT), leading ethics and policy research for the center. He seved as Co-Director for CMaT's Engineering Workforce Development activities from 2017 to 2022. His research focuses on the intersection between public policy and bioethics. Much of his work has examined the development of stem cell science, particularly research using human embryonic stem cells, and the translation of novel cell therapies. He also writes extensively on the oversight of contentious areas of medicine, such as assisted reproductive technology. In 2012, he received a NSF CAREER award to examine the impact of ethical controversy on graduate science education and the development of scientific careers.  He serves as Vice-Chair for Bioethics on the International Society for Cell & Genel Therapy’s Committee on the Ethics of Cell and Gene Therapy and recently completed a three-year term as an elected member of the Board of Directors of the American Society for Bioethics and Humanities. He is also a long-time member of the International Society for Stem Cell Research, the Association for Public Policy Analysis and Management, and the American Association for the Advancement of Science.

Aaron has a long-standing interest in science communication and is the author of Cloning: A Beginner's Guide (Oneworld Publications, 2007), an accessible introduction to the science of cloning and embryonic stem cells and the ethical and policy controversies this science inspires. He was an AAAS Leshner Leadership Institute Public Engagement Fellow for 2019-2020. You can follow Aaron on twitter at @aarondlevine.

He completed his Ph.D. in Public Affairs at Princeton University, where his dissertation research examined the impact of public policy on the development of human embryonic stem cell science.  He also holds an M. Phil. from the University of Cambridge, where, as a Churchill Scholar, he studied computational biology at the Sanger Centre and developed algorithms to help analyze the human genome sequence, and a B.S. in Biology from the University of North Carolina at Chapel Hill, where he was a Morehead Scholar.